Targeting SALL4 by entinostat in lung cancer

The overall survival of lung cancer patients remains dismal despite the availability of targeted therapies. Oncofetal protein SALL4 is a novel cancer target. We herein report that SALL4 was aberrantly expressed in a subset of lung cancer patients with poor survival. SALL4 silencing by RNA interferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Kol Jia, Li, Ailing, Ou, Wen-Bin, Hong, Clarice Kit Yee, Zhao, Wenxiu, Wang, Fei, Tatetsu, Hiro, Yan, Benedict, Qi, Lihua, Fletcher, Jonathan A., Yang, Henry, Soo, Ross, Tenen, Daniel G., Chai, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342750/
https://www.ncbi.nlm.nih.gov/pubmed/27705911
http://dx.doi.org/10.18632/oncotarget.12251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342750/
https://www.ncbi.nlm.nih.gov/pubmed/27705911
http://dx.doi.org/10.18632/oncotarget.12251

Ejemplares similares